← Search all jobs

Sr. Medical Director, Clinical Development (Psychiatry)

Alkermes plc.

Waltham, MA · Posted June 12, 2026

Just laid off? Start here: a plan for the first weeks

Want recruiters in Clinical to be able to find you?

Roles at this level, like this one at Alkermes plc., are often filled through recruiters.

See every open role at Alkermes plc.

More in Massachusetts job market · Pharmaceuticals & Biotech · Clinical jobs

More roles at Alkermes plc.

Where Waltham, MA ranks

Where Waltham, MA placed in our monthly rankings, month by month. Each month stays online at its own address.

Rankings about clinical jobs

Clinical jobs · Top Clinical employers · All rankings

How AI is used in this kind of work

AI use among medical and health services managers is little observed so far. Measured exposure for medical and health services managers: 7% (little observed).

Share of this job’s tasks that AI is already used for at work, from real usage. It is not a forecast of job loss, and a low number means no use seen yet. Source: Anthropic Economic Index.

Check how this applies to your own job

Skills this job asks for

Say which you have and which you want to build. We use it to match you to jobs like this one.

About the job

This is a high impact position with great visibility across all levels of the Alkermes organization.

This position will have critical responsibilities in the clinical department involved in the development of therapies for neuropsychiatric indications. Key trial related responsibilities include development of study protocols, medical review of clinical trial data and generation of clinical study reports. Additionally, the Sr Medical Director will participate in internal strategy regarding future therapeutic priorities and interact externally with key global regulatory authorities, industry and scientific organizations, as well as external key thought leaders. This position will work cross-functionally to ensure projects are coordinated with partners from multiple departments within Alkermes including regulatory, preclinical research, clinical pharmacology, translational medicine, toxicology, CMC, new product planning, project management, patient engagement, health economics, legal, finance, medical affairs and commercial.

Responsible for protocol design and execution across clinical research trials in neuropsychiatric disorders

Serves as the Global Clinical Lead for 1 or more programs, including leadership of the clinical subteams of those programs

Direct authorship contributions in protocols, clinical study reports, study documents, regulatory documents, and external publications

Provide medical review of clinical trial data and medical monitoring (in conjunction with a CRO medical monitor) of Phase 2 and Phase 3 clinical trials

Interact with senior management and serve as a standing member of one or more project team(s)

Contribute to strategic discussions related to clinical development plans and indication prioritization

May include mentoring of more junior clinical research colleagues and/or clinical scientists

Represent the company to external audiences, including clinical sites, industry partners, and patient advocacy groups

In collaboration with clinical operations, oversee and coordinate the operational aspects of ongoing projects to ensure that goals of time, cost and quality performance expectation are met

Ensure that standard operating procedures (SOP) for Clinical Development facilitate the development of effective clinical research programs and are compliant with clinical/medical and industry standards

Identify and develop collaborative relationships with key investigators, and key thought leaders globally. Attend and oversee clinical advisory boards, investigator meetings, and attend and present at major medical conferences

Critically review and contribute to regulatory interactions (such as INDs and NDAs)

Depending on level, may participate in business development activities

Requires an MD with drug development experience in psychiatry

At least 5-7 years of experience in the pharmaceutical industry

A business-focused individual, with experience in all aspects of drug development across early and late stage clinical programs

A person who has built on their medical expertise and successfully applied this to enhance the development of new chemical entities (NCEs)

Experience interacting with global regulatory agencies, including successful NDA or BLA submissions and approvals, is highly desired

Outstanding written and verbal communication, with experience interacting with and presenting to senior management and external audiences

Ability to manage complexity and ambiguity in a highly matrixed work environment

Displays strong leadership and collaborative interpersonal skills

Ability to work independently, prioritize tasks efficiently, and meet expected time frames

Ability to perform thorough reviews of various medical and trial related documents in a timely manner

Domestic and international travel (approximately 25%) is required

Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This position is eligible for the hybrid workplace model, requiring work to be completed onsite at our Waltham, MA office at least 3 days per week. This role is not eligible for fully remote work.

The annual base salary for this position ranges from $340,000 to $360,000. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here

#LI-MB1

Why join Team Alkermes?

Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.

We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.